Delivery Order SPE2DR25D1051-SPE2DR26F39B3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,110.14 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of December 22, 2025, and represents a non-set-aside competitive award. Performance will occur at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $4,031.28 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 7, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation was issued on November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $18,442.74 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 29, 2025. This non-competitive award was issued on September 26, 2025, under a firm fixed-price contract type. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,004.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $11,451.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of July 29, 2025, just one day following the award date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents, valued at $1,269.91. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $40,167.61 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under a larger contract vehicle supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $10,293.12 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price delivery order with an ultimate completion date of November 25, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $12,107.97 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This firm fixed price, competitively awarded contract was executed on November 12, 2025, with an ultimate completion date of November 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,934.20 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 17, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is...
- SPE2DR25D1051Indefinite Delivery Contract
- SPE2DR25D1051-SPE2DR26F39B3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,436.76 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This non-competitive, firm fixed price delivery order was awarded on January 5, 2026, with an ultimate completion date of January 6, 2026. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle designated SPE2DX and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Vivitrol—an extended-release naltrexone formulation used in opioid dependence treatment—demonstrates the company's ongoing role in supplying specialized pharmaceutical commodities to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 1/4/26 |